Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

9.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward developing a patient reported outcomes measure for children with heart failure: A qualitative study design.

American heart journal·2026
Same author

DiaBetter Together: Outcomes of a Randomized Controlled Trial Evaluating a Peer Mentor Behavioral Intervention for Young Adults With Type 1 Diabetes During the Transfer From Pediatric to Adult Care.

Diabetes care·2026
Same author

Mitigating Glycemic Disparities: Understanding Contributions of Sociodemographic Variables in the Teamwork, Targets, Technology, and Tight Glycemia (4T) Study.

The Journal of pediatrics·2026
Same author

Building the evidence to address disparities in type 1 diabetes (BEAD-T1D): methods and design of a study examining barriers and promoters to diabetes device use in families with public insurance.

Frontiers in endocrinology·2026
Same author

How to communicate with individuals and caregivers at the time of presymptomatic type 1 diabetes diagnosis.

Postgraduate medicine·2026
Same author

Real-world experience with teplizumab in stage 2 type 1 diabetes: a plain language summary.

Therapeutic advances in endocrinology and metabolism·2026

Related Experiment Video

Updated: Apr 14, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

The emerging diabetes online community.

Marisa E Hilliard1, Kerri M Sparling, Jeff Hitchcock

  • 1Baylor College of Medicine, Department of Pediatrics, 1102 Bates Avenue, Suite 940, Houston, TX, USA. Marisa.Hilliard@bcm.edu.

Current Diabetes Reviews
|April 23, 2015
PubMed
Summary

The Diabetes Online Community (DOC) offers peer support and information sharing, positively impacting emotional well-being and diabetes management behaviors. Further research is needed to fully understand its effects on glycemic control and quality of life.

More Related Videos

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

2.4K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Related Experiment Videos

Last Updated: Apr 14, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

2.4K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Area of Science:

  • Digital Health
  • Patient Support Networks
  • Diabetes Management

Background:

  • Diabetes self-management presents significant challenges, often leading to isolation and burnout.
  • The internet facilitates connections among individuals with diabetes, offering solutions to these difficulties.
  • The Diabetes Online Community (DOC) has emerged as a key platform for peer interaction and support.

Purpose of the Study:

  • To outline the platforms used by the Diabetes Online Community (DOC).
  • To explore motivations for and risks associated with online diabetes engagement.
  • To review existing research on the impact of DOC participation on diabetes outcomes.

Main Methods:

  • A review of research and online content pertaining to diabetes online activity.
  • Utilization of excerpts from DOC writings to illustrate central themes.
  • Development of guidelines for effective participation in DOC activities for various stakeholders.

Main Results:

  • Key themes in DOC participation include peer support, advocacy, self-expression, information exchange, data management, and humor.
  • Potential risks involve misinformation and privacy concerns, though data on negative outcomes are scarce.
  • Initial research indicates positive effects on emotional experiences, attitudes, and diabetes management behaviors, with limited data on glycemic outcomes.

Conclusions:

  • The DOC is rapidly expanding in participants, activities, and platforms.
  • The internet enhances communication and support networks for individuals with diabetes, healthcare providers, and the public.
  • Further research is essential to evaluate the impact of DOC participation on self-management, quality of life, and glycemic control, and to optimize its benefits.